Montelukast Sodium Market Share

Statistics for the 2023 & 2024 Montelukast Sodium market share, created by Mordor Intelligence™ Industry Reports. Montelukast Sodium share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Montelukast Sodium Industry

The montelukast sodium market is moderately competitive and consists of several major players. Some of the companies that are currently dominating the market are Merck & Co. Inc., Morepen Laboratories, Teva Pharmaceuticals USA Inc., Mylan NV, Cipla Limited, Intas Pharmaceuticals Ltd, Sun Pharma, Apotex Inc, Sanyo Chemical Industries Ltd, and Delmar Chemicals Inc.

Montelukast Sodium Market Leaders

  1. Merck & Co., Inc.

  2. Morepen Laboratories

  3. Teva Pharmaceuticals USA, Inc.

  4. Cipla Limited

  5. Sanofi Aventis

*Disclaimer: Major Players sorted in no particular order

Montelukast Sodium Market Concentration

Montelukast Sodium Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)